Advertisement

Shingles Vaccination of U.S. Adults Aged 50–59 Years and ≥60 Years Before Recommendations for Use of Recombinant Zoster Vaccine

      Introduction

      In 2006, zoster vaccine live was recommended for adults aged ≥60 years. In 2011, zoster vaccine live was approved for use but not recommended for adults aged 50–59 years. This study assessed zoster vaccine live coverage among adults aged 50–59 years and ≥60 years.

      Methods

      Data from the 20132017 National Health Interview Surveys were analyzed in 2019 to estimate national zoster vaccine live coverage among adults aged ≥50 years. State-specific zoster vaccine live coverage among adults aged ≥50 years was assessed using 2017 Behavioral Risk Factor Surveillance System data.

      Results

      Among adults aged 50–59 years, zoster vaccine live coverage was 5.7% in 2017, ranging from 4% to 6% during 20132017 (test for trend, p>0.05). Zoster vaccine live coverage among adults aged 50–59 years ranged from 5.8% in Pennsylvania to 14.7% in South Dakota. By 2017, zoster vaccine live was received by 34.9% of adults aged ≥60 years, a significant increase from 24.2% in 2013. Zoster vaccine live coverage among adults aged ≥60 years in 2017 ranged from 26.0% in Mississippi to 51.8% in Vermont. In 2017, major characteristics significantly associated with increased likelihood of zoster vaccine live vaccination among adults aged 50–59 years and ≥60 years were older age, having 4 to 9 physician contacts in the past 12 months, and having a usual place for health care.

      Conclusions

      This study provides an assessment of zoster vaccine live coverage among adults aged ≥50 years before the newly recommended recombinant zoster vaccine came into widespread use. Providers should routinely assess adults’ vaccination status and strongly recommend or offer needed vaccines to their patients.
      To read this article in full you will need to make a payment

      Purchase one-time access:

      Academic & Personal: 24 hour online accessCorporate R&D Professionals: 24 hour online access
      One-time access price info
      • For academic or personal research use, select 'Academic and Personal'
      • For corporate R&D use, select 'Corporate R&D Professionals'

      Subscribe:

      Subscribe to American Journal of Preventive Medicine
      Already a print subscriber? Claim online access
      Already an online subscriber? Sign in
      Institutional Access: Sign in to ScienceDirect

      REFERENCES

        • Thomas SL
        • Hall AJ.
        What does epidemiology tell us about risk factors for herpes zoster?.
        Lancet Infect Dis. 2004; 4: 26-33
        • Oxman MN
        • Levin MJ
        • Johnson GR
        • et al.
        A vaccine to prevent herpes zoster and postherpetic neuralgia in older adults.
        N Engl J Med. 2005; 352: 2271-2284
        • Yawn BP
        • Saddier P
        • Wollan PC
        • St Sauver JL
        • Kurland MJ
        • Sy LS
        A population-based study of the incidence and complication rates of herpes zoster before zoster vaccine introduction.
        Mayo Clin Proc. 2007; 82: 1341-1349
        • Harpaz R
        • Ortega-Sanchez IR
        Seward JF; Advisory Committee on Imunization Practices (ACIP) Centers for Disease Control and Prevention (CDC). Prevention of herpes zoster: recommendations of the Advisory Committee on Immunization Practices (ACIP).
        MMWR Recomm Rep. 2008; 57: 1-CE4
        • Centers for Disease Control and Prevention (CDC)
        Update on herpes zoster vaccine: licensure for persons aged 50 through 59 years.
        MMWR Morb Mortal Wkly Rep. 2011; 60: 1528
        • Hales CM
        • Harpaz R
        • Ortega-Sanchez I
        • Bialek SR
        Centers for Disease Control and Prevention (CDC). Update on recommendations for use of herpes zoster vaccine.
        MMWR Morb Mortal Wkly Rep. 2014; 63: 729-731
        • Dooling KL
        • Guo A
        • Patel M
        • et al.
        Recommendations of the Advisory Committee on Immunization Practices for use of herpes zoster vaccines.
        MMWR Morb Mortal Wkly Rep. 2018; 67: 103-108
        • CDC, HHS
        National Health Interview Survey; 2017.
        2018 (Published July 17,)
        • CDC
        Behavioral Risk Factor Surveillance System: overview– BRFSS 2017.
        2018 (Published July 16,)
        • CDC
        The Behavioral Risk Factor Surveillance System: 2017 summary data quality report.
        2018 (Published July 13,)
      1. HHS. Immunization and infectious diseases.www.healthypeople.gov/2020/topics-objectives/topic/immunization-and-infectious-diseases/objectives. Accessed January 15, 2019.

        • Hurley LP
        • Lindley MC
        • Harpaz R
        • et al.
        Barriers to the use of herpes zoster vaccine.
        Ann Intern Med. 2010; 152: 555-560
        • Campos-Outcalt D
        • Jeffcott-Pera M
        • Carter-Smith P
        • Schoof BK
        • Young HF
        Vaccines provided by family physicians.
        Ann Fam Med. 2010; 8: 507-510
        • Wang J
        • Ford LJ
        • Wingate L
        • et al.
        Effect of pharmacist intervention on herpes zoster vaccination in community pharmacies.
        J Am Pharm Assoc. 2013; 53: 46-53
        • Lindley MC
        • Wortley PM
        • Winston CA
        • Bardenheier BH
        The role of attitudes in understanding disparities in adult influenza vaccination.
        Am J Prev Med. 2006; 31: 281-285
        • Link MW
        • Ahluwalia IB
        • Euler GL
        • Bridges CB
        • Chu SY
        • Wortley PM
        Racial and ethnic disparities in influenza vaccination coverage among adults during the 2004-2005 season.
        Am J Epidemiol. 2006; 163: 571-578
        • Bach PB
        • Pham HH
        • Schrag D
        • Tate RC
        • Hargraves JL
        Primary care physicians who treat blacks and whites.
        N Engl J Med. 2004; 351: 575-584
        • Schneider EC
        • Zaslavsky AM
        • Epstein AM
        Racial disparities in the quality of care for enrollees in Medicare managed care.
        JAMA. 2002; 287: 1288-1294
        • Gemson DH
        • Elinson J
        • Messeri P
        Differences in physician prevention practice patterns for white and minority patients.
        J Community Health. 1988; 13: 53-64
        • Lu PJ
        • Singleton JA
        • Euler GL
        • Williams WW
        • Bridges CB
        Seasonal influenza vaccination of adult populations, United States, 2005-2011.
        Am J Epidemiol. 2013; 178: 1478-1487
        • Lu PJ
        • Santibanez TA
        • Williams WW
        • et al.
        Surveillance of influenza vaccination coverage – United States, 2007-08 through 2011-12 influenza seasons.
        MMWR Surveill Summ. 2013; 62: 1-28
        • Lu PJ
        • O'Halloran A
        • Williams WW
        • Lindley MC
        • Farrall S
        • Bridges CB
        Racial and ethnic disparities in vaccination coverage among adult populations in the U.S.
        Am J Prev Med. 2015; 49: S412-S425
        • U.S. Government Accountability Office
        Report to congressional committees. Medicare—many factors, including administrative challenges, affect access to Part D vaccinations.
        2011
        www.gao.gov/products/GAO-12-61
        Date accessed: October 10, 2019
        (Published December)
        • Klaiman T
        • Ibrahim JK
        State health department structure and pandemic planning.
        J Public Health Manag Pract. 2010; 16: E1-E7
        • Nelson DE
        • Bland S
        • Powell-Griner E
        • et al.
        State trends in health risk factors and receipt of clinical preventive services among U.S. adults during the 1990s.
        JAMA. 2002; 287: 2659-2667
        • Holtzman D
        • Powell-Griner E
        • Bolen JC
        • Rhodes L
        State- and sex-specific prevalence of selected characteristics – Behavioral Risk Factor Surveillance System, 1996 and 1997.
        MMWR CDC Surveill Summ. 2000; 49: 1-39
        • Xu F
        • Mawokomatanda T
        • Flegel D
        • et al.
        Surveillance for certain health behaviors among selected local areas – Behavioral Risk Factor Surveillance System, 2011.
        MMWR Surveill Summ. 2014; 63: 1-149
        • O'Halloran AC
        • Lu PJ
        • Williams WW
        • Bridges CB
        • Singleton JA
        Influenza vaccination coverage among people with high-risk conditions in the U.S.
        Am J Prev Med. 2016; 50: e15-e26
        • CDC
        AdultVaxView.
        2019 (Updated May 2,)
        • CDC
        FluVaxView.
        2019
        www.cdc.gov/flu/fluvaxview/
        Date accessed: February 22, 2019
        (Updated September 26,)
        • CDC
        Guide to community preventive services.
        2018
        www.thecommunityguide.org/index.html
        Date accessed: June 19, 2019
        (Updated February 15,)
        • Lu PJ
        • O'Halloran A
        • Williams WW
        Impact of health insurance status on vaccination coverage among adult populations.
        Am J Prev Med. 2015; 48: 647-661
        • CDC
        Hepatitis B vaccination coverage among adults–United States, 2004.
        MMWR Morb Mortal Wkly Rep. 2006; 55: 509-511
        • CDC
        NHIS questionnaire - sample adult; 2018.
        2019 (Published June 12,)
        • Rolnick SJ
        • Parker ED
        • Nordin JD
        • et al.
        Self-report compared to electronic medical record across eight adult vaccines: do results vary by demographic factors.
        Vaccine. 2013; 31: 3928-3935
        • National Vaccine Advisory Committee
        Recommendations from the National Vaccine Advisory Committee: standards for adult immunization practice.
        Public Health Rep. 2014; 129: 115-123
        • CDC
        Shingles (herpes zoster): vaccination.
        2019
        www.cdc.gov/shingles/vaccination.html
        Date accessed: October 19, 2019
        (Updated July 1,)